MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
87.7 M |
Marktkapitalisierung |
$ 796 M |
EBITDA (LTM) |
$ -303 M |
P/E (LTM) |
-4.166667 |
P/S (LTM) |
17.215065 |
EPS (LTM) |
-3.18 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Pfizer
PFE
|
$ 29.58 | 0.54 % | $ 168 B | NYSE,SPB | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 37.88 | 0.5 % | $ 2.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 19.67 | 1.08 % | $ 31.1 B | NYSE |  Japan |
 |
Revolution Medicines
RVMD
|
$ 177.96 | 0.22 % | $ 33.8 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 86.17 | 0.6 % | $ 5.6 B | Nasdaq Global Market,SPB | USA |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.26 | 0.9 % | $ 251 M | Nasdaq Global Select Market | USA |
 |
Sana Biotechnology
SANA
|
$ 2.27 | 6.22 % | $ 575 M | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.36 | 4.61 % | $ 4.97 B | Nasdaq Global Select Market | USA |
 |
Zoetis
ZTS
|
$ 79.38 | 1.22 % | $ 35.2 B | NYSE,SPB | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 14.54 | 1.81 % | $ 1.43 B | Nasdaq Global Select Market,SPB | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.96 | 2.62 % | $ 1.32 B | Nasdaq Capital Market |  Israel |
 |
Cleveland BioLabs, Inc.
CBLI
|
- | -7.31 % | $ 49 M | Nasdaq Capital Market | USA |
 |
Zymeworks
ZYME
|
$ 25.03 | 0.16 % | $ 1.29 B | NYSE |  Canada |
 |
AC Immune SA
ACIU
|
$ 2.39 | 2.08 % | $ 241 M | Nasdaq Global Market |  Schweiz |
 |
Five Prime Therapeutics, Inc.
FPRX
|
- | - | $ 1.77 B | Nasdaq Global Select Market | USA |
 |
Adagene
ADAG
|
$ 2.06 | 4.8 % | $ 122 M | Nasdaq Global Market |  China |
 |
Adial Pharmaceuticals
ADIL
|
$ 3.49 | 11.15 % | $ 2.33 M | Nasdaq Capital Market | USA |
 |
ADC Therapeutics SA
ADCT
|
$ 1.4 | 0.34 % | $ 178 M | NYSE | Schweiz |
 |
ADMA Biologics
ADMA
|
$ 10.68 | 3.77 % | $ 2.55 B | Nasdaq Global Market | USA |
 |
Assembly Biosciences
ASMB
|
$ 20.09 | 0.19 % | $ 225 M | Nasdaq Global Select Market,SPB | USA |
 |
Allogene Therapeutics
ALLO
|
$ 1.31 | 3.08 % | $ 289 M | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 432.49 | 0.08 % | $ 233 B | Nasdaq Global Select Market,SPB | USA |
 |
Ardelyx
ARDX
|
$ 3.09 | 2.51 % | $ 745 M | Nasdaq Global Market | USA |
 |
Armata Pharmaceuticals
ARMP
|
$ 3.37 | 9.06 % | $ 122 M | NYSE American | USA |
 |
Artelo Biosciences
ARTL
|
$ 2.7 | 0.36 % | $ 511 K | Nasdaq Global Select Market | USA |
 |
Biofrontera AG
BFRA
|
- | -8.24 % | $ 105 M | Nasdaq Capital Market |  Germany |
 |
Bicycle Therapeutics plc
BCYC
|
$ 3.46 | 2.56 % | $ 240 M | Nasdaq Global Select Market |  Britain |
 |
Catabasis Pharmaceuticals, Inc.
CATB
|
- | -6.97 % | $ 657 M | Nasdaq Global Market | USA |
 |
Beam Therapeutics
BEAM
|
$ 23.47 | 4.57 % | $ 2.32 B | Nasdaq Global Select Market | USA |
 |
China Biologic Products Holdings, Inc.
CBPO
|
- | 1.68 % | $ 4.65 B | Nasdaq Global Select Market | China |
 |
Benitec Biopharma
BNTC
|
$ 8.11 | 2.05 % | $ 378 M | Nasdaq Capital Market | USA |
 |
BioNTech SE
BNTX
|
$ 87.71 | 1.74 % | $ 21.2 B | Nasdaq Global Select Market | Germany |
 |
ANI Pharmaceuticals
ANIP
|
$ 72.29 | 0.01 % | $ 1.45 B | Nasdaq Global Market,SPB | USA |
 |
C4 Therapeutics
CCCC
|
$ 2.77 | 0.36 % | $ 230 M | Nasdaq Global Select Market | USA |
 |
Cerus Corporation
CERS
|
$ 2.18 | 0.66 % | $ 415 M | Nasdaq Global Market | USA |
 |
Certara
CERT
|
$ 9.37 | 0.26 % | $ 1.5 B | Nasdaq Global Select Market | USA |
 |
Flexion Therapeutics, Inc.
FLXN
|
- | - | $ 459 M | Nasdaq Global Market | USA |
 |
Coherus BioSciences
CHRS
|
$ 0.99 | 1.9 % | $ 116 M | Nasdaq Global Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 110.16 | 0.47 % | $ 11.4 B | Nasdaq Capital Market,SPB | USA |
 |
CorMedix
CRMD
|
$ 7.26 | 0.95 % | $ 523 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 49.25 | 2.59 % | $ 4.43 B | Nasdaq Global Market,SPB | Schweiz |
 |
Greenwich LifeSciences
GLSI
|
$ 14.55 | 1.48 % | $ 197 M | Nasdaq Capital Market | USA |
 |
Champions Oncology
CSBR
|
$ 4.7 | 0.94 % | $ 65 M | Nasdaq Capital Market | USA |
 |
Heat Biologics, Inc.
HTBX
|
- | -5.76 % | $ 99.8 M | Nasdaq Capital Market | USA |
 |
Cue Biopharma
CUE
|
$ 16.71 | 0.38 % | $ 1.58 B | Nasdaq Capital Market,SPB | USA |
 |
Kindred Biosciences, Inc.
KIN
|
- | 0.11 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
DBV Technologies S.A.
DBVT
|
$ 9.05 | 2.71 % | $ 1.26 B | Nasdaq Global Select Market |  France |
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.62 | 8.64 % | $ 16.8 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market | China |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.13 | 6.6 % | $ 35.3 M | NYSE American | USA |